Covance's acquisition will create business ops, Quintiles chief says; INC shuffles its C-suite;

> LabCorp's ($LH) soon-to-close acquisition of Covance ($CVD) will create opportunities for Quintiles ($Q), CEO Tom Pike said. More

> INC Research ($INCR) has changed things around in its C-suite, promoting COO Alistair Macdonald to president and appointing CNS President Michael Gibertini to the newly created role of president of clinical development. News

> Charles River Laboratories ($CRL) is considering reopening a long-dormant preclinical research operation in Massachusetts. Story

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.